Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal.
4-Oxonon-2-enal (4ONE) was demonstrated to be a product of lipid peroxidation, and previous studies found that it was highly reactive toward DNA and protein. The present study sought to determine whether carbonyl reductase (CR) catalyzes reduction of 4ONE, representing a potential pathway for metabolism of the lipid peroxidation product. Recombinant CR was cloned from a human liver cDNA library, expressed in Escherichia coli, and purified by metal chelate chromatography. Both 4ONE and its glutathione conjugate were found to be substrates for CR, and kinetic parameters were calculated. TLC analysis of reaction products revealed the presence of three compounds, two of which were identified as 4-hydroxynon-2-enal (4HNE) and 1-hydroxynon-2-en-4-one (1HNO). GC/MS analysis confirmed 4HNE and 1HNO and identified the unknown reaction product as 4-oxononanal (4ONA). Analysis of oxime derivatives of the reaction products via LC/MS confirmed the unknown as 4ONA. The time course for CR-mediated, NADPH-dependent 4ONE reduction and appearance of 4HNE and 1HNO was determined using HPLC, demonstrating 4HNE to be a major product and 1HNO and 4ONA to be minor products. Simulated structures of 4ONE in the active site of CR/NADPH calculated via docking experiments predict the ketone positioned as primary hydride acceptor. Results of the present study demonstrate that 4ONE is a substrate for CR/NADPH and the enzyme may represent a pathway for biotransformation of the lipid. Furthermore, these findings reveal that CR catalyzes hydride transfer selectively to the ketone but also to the aldehyde and C=C of 4ONE, resulting in 4HNE, 1HNO, and 4ONA, respectively.
Department of Pharmaceutical Sciences, School of Pharmacy, The University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
Jonathan A
JA
Doorn
Edmund
E
Maser
Andreas
A
Blum
David J
DJ
Claffey
Dennis R
DR
Petersen
D000429:Alcohol Oxidoreductases / Q000037:antagonists & inhibitors / Q000737:chemistry*; D000449:Aldehyde Reductase; D000447:Aldehydes / Q000737:chemistry*; D000074408:Aldo-Keto Reductases; D000818:Animals; D002384:Catalysis; D002853:Chromatography, Liquid; D004791:Enzyme Inhibitors / Q000737:chemistry; D005231:Fatty Acids, Unsaturated / Q000737:chemistry*; D008401:Gas Chromatography-Mass Spectrometry; D006736:Horses; D006801:Humans; D015227:Lipid Peroxidation; D008958:Models, Molecular; D021241:Spectrometry, Mass, Electrospray Ionization; D013997:Time Factors
C101780:4-oxonon-2-enoic acid; D000447:Aldehydes; D004791:Enzyme Inhibitors; D005231:Fatty Acids, Unsaturated; D000429:Alcohol Oxidoreductases; D000074408:Aldo-Keto Reductases; C019642:alcohol dehydrogenase (NADP+); D000449:Aldehyde Reductase; C027576:4-hydroxy-2-nonenal